12/06/2026
Edit post
Deb Mayberry Tibbetts
Need more info call me 207*651*8914
The Medicare GLP-1 Bridge program begins July 1, 2026
(PROGRAM TO COVER WEIGHT LOSS USING GLP-1.)
Wegovy - Injections and tablets
Zepbound - KwikPen
Founday
Standard Medicare Part D does not cover GLP-1 drugs prescribed solely for weight loss. However, the Centers for Medicare & Medicaid Services (CMS) offers the temporary Medicare GLP-1 Bridge, allowing eligible beneficiaries to access select weight-loss medications for a flat $50 copayment per 30-day supply. Key Program Details Program Dates: Runs from July 1, 2026, through December 31, 2027.Eligible Medications: Includes Wegovy (injections and tablets), Zepbound (KwikPen), and Foundayo.
Qualifying Criteria: To participate, you must be 18 or older, have a Body Mass Index (BMI) of 35 or higher, and be enrolled in an eligible Medicare Part D plan. Prior Authorization: Your doctor must submit a prescription and a prior authorization request directly to the CMS central processor. Diabetes and Cardiovascular Coverage If you are taking GLP-1 drugs (like Ozempic) for Type 2 diabetes management or to lower the risk of cardiovascular disease, these medications are standardly covered by Medicare Part D. The exact out-of-pocket cost will depend on your specific plan's formulary and deductible, rather than the flat $50 Bridge program fee.
How to Get Started
Talk to Your Doctor:
Discuss whether a weight-loss GLP-1 is right for you and if you meet the BMI requirement.Review CMS Guidelines: Consult the official Medicare GLP-1 Bridge page for full details.
Get Prior Authorization: Once you have a prescription, your healthcare provider must submit a Medicare GLP-1 Bridge Prior Authorization Request to CMS.